Press Releases
Zavante Therapeutics Announce Agreement To Assess ZOLYD™ for Lower Respiratory Tract Infections With NIAID
Zavante Therapeutics, Inc., a biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients, has signed a Clinical Trial Agreement...
Packaging & Labelling
Research reveals costly implementation is the biggest barrier to serialization compliance
According to new industry research more than half (54%) of industry professionals believe that the cost of implementing serialization is the greatest hurdle to...
Press Releases
Bioanalytical Laboratory Expansion at Its USA Headquarters Completed By BioAgilytix
Durham, NC—BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has completed the expansion of the laboratory facility...
Drug Research
NeuroRx awarded FDA Fast Track Designation for first drug regimen targeting suicide in bipolar depression
NeuroRX , Acute Suicidal Ideation and Behavior (ASIB) , NRX-100 (ketamine HCl) , NRX-100 (ketamine HCl) , NeuroRx, a clinical stage biopharmacompany developing the...
Press Releases
mProve Health and Greenphire Partner to Delivera First-of-its-Kind Patient Engagement Solution
mProve Health, a leading provider of mobile technologies for patient engagement and electronic clinical outcome assessments (eCOA), andGreenphire, the global leader in clinical payment...
Press Releases
FDA approves Mylotarg for treatment of acute myeloid leukemia
Pfizer Inc. announced that the U.S. Food and Drug Administration approved MYLOTARG™ (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML),...
Clinical Trials
Presented in VIVA Late Breaking Clinical Trials Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data
Medtronic plc data announced reinforce the durability and safety of the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) in patients with peripheral arterial disease (PAD). ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
